Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

alvogen ipco s.ar.l - kapecitabin - filmsko obložena tableta - kapecitabin 150 mg / 1 tableta - kapecitabin

Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

alvogen ipco s.ar.l - kapecitabin - filmsko obložena tableta - kapecitabin 500 mg / 1 tableta - kapecitabin

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

baxter holding b.v. - doksorubicinijev klorid - sarcoma, kaposi; multiple myeloma; ovarian neoplasms; breast neoplasms - antineoplastična sredstva - caelyx pegylated liposomal je navedeno:kot monotherapy za bolnike z metastatskim rakom dojke, kjer je povečana srčna tveganja;za zdravljenje advanced rak na jajčnikih pri ženskah, ki niso uspeli v prvi vrstici platinum, ki temelji kemoterapijo režim;v kombinaciji z bortezomib za zdravljenje postopno več plazmocitom pri bolnikih, ki so prejeli vsaj en pred terapijo in ki so že obdelani ali ki so neprimerni za presaditev kostnega mozga;za zdravljenje hiv kaposi ' s sarkom (ks) pri bolnikih z nizko cd4 šteje (.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - kapecitabin - stomach neoplasms; breast neoplasms; colonic neoplasms; colorectal neoplasms - kapecitabin - kapecitabin je indiciran za adjuvantno zdravljenje bolnikov po operaciji stopnje iii (dukes 'stadij c) raka debelega črevesa. capecitabine je primerna za zdravljenje metastatskega raka debelega črevesa in danke. capecitabine je določen za prvo linijo zdravljenja naprednih raka želodca v kombinaciji z platinum, ki temelji režim. capecitabine v kombinaciji z docetaxel je indiciran za zdravljenje bolnikov z lokalno napredno ali metastatskega raka dojke po okvari citotoksična kemoterapija. predhodno zdravljenje bi moralo vključiti antraciklin. capecitabine je prikazano tudi kot monotherapy za zdravljenje bolnikov z lokalno napredno ali metastatskega raka dojke po okvari taxanes in anthracycline-ki vsebujejo kemoterapijo režim ali za koga še anthracycline zdravljenje ni navedeno.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

yes pharmaceutical development services gmbh - doksorubicinijev klorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

prašek in vehikel za raztopino za injiciranje - interferon alfa-2b

Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

prašek in vehikel za raztopino za injiciranje - interferon alfa-2b

Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

raztopina za injiciranje ali infundiranje - interferon alfa-2b

Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

prašek in vehikel za raztopino za injiciranje - interferon alfa-2b